<DOC>
	<DOCNO>NCT00089947</DOCNO>
	<brief_summary>This study involve use drug call Thymoglobulin , approve US treat kidney transplant rejection Canada treat prevent kidney transplant rejection . This study evaluate effect Thymoglobulin reduce dos steroid prevent renal transplant rejection provide basis future evaluation Thymoglobulin immunosuppressive agent help prevent renal transplant rejection . Subjects meet inclusion exclusion criterion eligible participate study . In addition standard treatment , study participant receive either Thymoglobulin rapid discontinuation steroid steroid per hospital standard least first 90 day transplant . The treatment assignment random choose subject physician . Subjects monitor treatment Thymoglobulin transplant hospitalization . Additional subject monitoring occur Months 1 , 3 , 6 12 follow transplant . Approximately 150 study subject 15-20 transplant center United States enrol .</brief_summary>
	<brief_title>A Study Evaluate Effect Thymoglobulin Reduced Doses Steroids Prevent Renal Transplant Rejection</brief_title>
	<detailed_description />
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<criteria>Adult live donor renal transplant recipient Age great equal 18 If female childbearing potential : ) must lactate ; b ) must negative serum Bhuman chorionic gonadotropin ( HCG ) test within 24 hour prior Study Day 0 ( Day Transplant ) ; c ) must agree practice acceptable reliable form contraception study ; Signed inform consent Human Leukocyte Antibody ( HLA ) identical match live donor transplant recipient &gt; 2 previous transplant Current panel reactive antibody ( PRA ) &gt; 20 % History positive crossmatch donor Active donor recipient serology positive human immunodeficiency virus ( HIV ) , Hepatitis B virus ( HBV ) Hepatitis C virus ( HCV ) Loss first kidney transplant &lt; 1 year History noncompliance clinical trial ( ) History chronic CS immunosuppressive use except inhaled CS treat asthma Use investigational product 90 day prior screen Requirement multiple organ transplant Patient without function urinary bladder prior transplant ( e.g . patient self catheterization exclude ) Known contraindication administration rabbit antithymocyte globulin Currently abuse drug alcohol In opinion investigator , high risk poor compliance In opinion investigator , significant medical psychosocial problem unstable disease state warrant exclusion study . Examples significant problem include , limited morbid obesity severe cardiac disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Anti-T cell antibody</keyword>
	<keyword>Living Donor Renal Transplantation</keyword>
	<keyword>Acute Renal Allograft Rejection</keyword>
	<keyword>Induction Therapy Reduction Calcineurin inhibitor</keyword>
</DOC>